VANI
$1.21
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.
Intraday
Recent News
Insiders Are Still Scooping Up Under Armour and WR Berkley Shares
Insiders continue to scoop up Under Armour and W.R. Berkley shares, and a public offering of International Tower Hill Mines shares prompted huge insider purchases as well.
GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window
The CEO of GameStop just picked up a million shares, and insiders are returning for more shares of Under Armour, Mission Produce, and more.
Insiders Rewarded With US$1.9m Addition To Investment As Vivani Medical Stock Hits US$110m
Insiders who bought Vivani Medical, Inc. ( NASDAQ:VANI ) stock in the last 12 months were richly rewarded last week...
Insiders hold 43% of Vivani Medical, Inc. (NASDAQ:VANI), and they've been buying recently
Key Insights Insiders appear to have a vested interest in Vivani Medical's growth, as seen by their sizeable ownership...
Vivani Medical: Q3 Earnings Snapshot
ALAMEDA, Calif. AP) — Vivani Medical, Inc. VANI) on Thursday reported a loss of $6.5 million in its third quarter.